26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A)
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
RNA Interference and Gene Delivery
Lipid metabolism and disorders
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A267–A267
- Publication date
- 27 March 2026
- Language
- EN